EP (etoposide + cisplatin, germ cell tumor)
Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.
Knowledge-base record for audit. Provisional clinical content: this is not a prescription. An oncologist must verify original sources, applicability and review status. Full rules and constraints are in the YAML.
| Components | DRUG-ETOPOSIDE DRUG-CISPLATIN |
|---|
| ID | REG-EP-GCT |
|---|---|
| Type | Regimen |
| Status | reviewed 2026-05-04 | pending_clinical_signoff |
| Diseases | None declared |
| Sources | None declared |
Used By
Algorithms
ALGO-GCT-METASTATIC-1L- ALGO-GCT-METASTATIC-1L
Indication
IND-GCT-METASTATIC-1L-EP- IND-GCT-METASTATIC-1L-EP